Associations between arsenic in drinking water and pterygium in southwestern Taiwan

Environmental Health Perspectives

Volumn 116, Issue 7, 2008, Pages 952-955

  Lin, Wei ^a   Wang, Shu Li ^b,c   Wu, Horng Jiun ^d   Chang, Kuang Hsi ^b   Yeh, Peter ^a,e   Chen, Chien Jen ^f   Guo, How Ran ^a,g  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e Pingtung Hospital   (Taiwan)

^f GENOMICS RESEARCH CENTER   (Taiwan)

^g NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Arsenic; Prevalence; Pterygium; Ultraviolet radiation; Water pollutant

Indexed keywords

ARSENIC; DRINKING WATER; WELL WATER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EYE EXAMINATION; EYE PHOTOGRAPHY; FEMALE; GENDER; GEOGRAPHIC DISTRIBUTION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PTERYGIUM; QUESTIONNAIRE; RISK ASSESSMENT; SAND; SUN EXPOSURE; TAIWAN; WATER POLLUTION; WORK ENVIRONMENT;

ADULT; AGED; ARSENIC; ENVIRONMENTAL EXPOSURE; EYE ABNORMALITIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PTERYGIUM; TAIWAN; TIME FACTORS; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 46749109271     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.11111     Document Type: Article

References (64)

1. Al-Bdour MD, Al-Latayfeh MM. 2004. Risk factors for pterygium in an adult Jordanian population. Acta Ophthalmol Scand 82:64-67.
2. Cantor KP. 2001 Invited commentary: arsenic and cancer of the urinary tract. Am J Epidemiol 153:422-423.
3. Chen C-J, Chiou H-Y, Chiang M-H, Lin L-J, Tai T-Y. 1996. Dose-response relationship between ischemic heart disease mortality and long-term arsenic exposure. Arterioscler Thromb Vasc Biol 16:504-510.
4. Chen C-J, Chung Y-C, Lin T-M, Wu H-Y. 1985. Malignant neoplasms among residents of a blackfoot disease-endemic area in Taiwan: high-arsenic artesian well water and cancers. J Cancer Res 45:5895-5899.
5. Chen C-J, Hsueh Y-M, Lai M-S, Shyu M-P, Chen S-Y, Wu M-M, et al. 1995. Increased prevalence of hypertension and long-term arsenic exposure. Hypertension 25:53-60.
6. Chen C-J, Wu M-M, Lee S-S, Wang J-D, Cheng S-H, Wu H-Y. 1988. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arterioscler Thromb Vasc Biol 8:452-460.
7. Chen C-W, Chuang S-S. 1976. Prevalence of pterygia among plain aborigines of Paiwan tribe of Chin-Fong-Hsian, Tai-Tong-Shien. Acta Societatis Ophthalmologicae Sinicae 15:27-34.
8. Chen C-W, Tsai Y-H, Lin C-Y, Chen S-R. 1964. An epidemiologic study of pterygium among Taiwan aborigines. Acta Societatis Ophthalmologicae Sinicae 3:12-19.
9. Chen J-K, Tsai R-J, Lin S-S. 1994. Fibroblasts isolated from human pterygia exhibit transformed cell characteristics. In Vitro Cell Dev Biol Anim 30:243-248.
10. Chen K-P, Wu H-Y, Wu T-C. 1962. Epidemiologic studies on blackfoot disease in Taiwan. 3. Physicochemical characteristics of drinking water in endemic blackfoot disease areas. Memoirs College Mad Natl Taiwan Univ 8:115-129.
11. Ch'i IC, Blackwell RQ. 1968. A controlled retrospective study of Blackfoot disease, an endemic peripheral gangrene disease in Taiwan. Am J Epidemiol 88:7-24.
12. Chiou H-Y, Huang W-I, Su C-L, Chang S-F, Hsu Y-H, Chen C-J. 1997. Dose-response relationship between prevalence of cerebrovascular disease and ingested inorganic arsenic. Stroke 28:1717-1723.
13. Chiou J-M, Wang S-L, Chen C-J, Deng C-R, Lin W, Tai TY. 2005. Arsenic ingestion and increased microvascular disease risk: observations from the south-western arseniasis-endemic area in Taiwan. Int J Epidemiol 34:936-943.
14. Dolezalová V. 1977. Is the occurrence of a temporal pterygium really so rare? Ophthalmologica 174:88-91.
15. Dushku N, John MK, Schultz GS, Reid TW. 2001. Pterygia pathogenesis: corneal invasion by matrix metalloproteinase expressing altered limbal epithelial basal cells. Arch Ophthalmol 119:695-706.
16. Dushku N, Reid TW. 1997. P53 expression in altered limbal basal cells of pingueculae, pterygia, and limbal tumors. Curr Eye Res 16:1179-1192.
17. Gazzard G, Saw SM, Farook M, Koh D, Widjaja D, Chia SE, et al. 2002. Pterygium in Indonesia: prevalence, severity and risk factors. Br J Ophthalmol 86:1341-1346.
18. Guo H-R. 2004. Arsenic level in drinking water and mortality of lung cancer (Taiwan). Cancer Causes Control 15:171-177.
19. Guo H-R, Chiang H-S, Hu H, Lipsitz SR, Monson RR. 1997. Arsenic in drinking water and incidence of urinary cancers. Epidemiology 8:545-550.
20. Guo H-R, Lipsitz SR, Hu H, Monson RR. 1998. Using ecological data to estimate a regression model for individual data: the association between arsenic in drinking water and incidence of skin cancer. Environ Res 79:82-93.
21. Guo H-R, Wang N-S, Hu H, Monson RR. 2004. Cell type specificity of lung cancer associated with arsenic ingestion. Cancer Epidemiol Biomarkers Prev 13:638-643.
22. Guo H-R, Yu H-S, Hu H, Monson RR. 2001. Arsenic in drinking water and skin cancers: cell-type specificity (Taiwan, ROC). Cancer Causes Control 12:909-916.
23. Ibrahim D, Froberg B, Wolf A, Rusyniak DE. 2006. Heavy metal poisoning: clinical presentations and pathophysiology. Clin Lab Med 26:67-97.
24. Jaros PA, DeLuise VP. 1988. Pingueculae and pterygia. Surv Ophthalmol 33:41-49.
25. Karai I, Horiguchi S. 1984. Pterygium in welders. Br J Ophthalmol 68:347-349.
26. Kria L, Ohira A, Amemiya T. 1996. Immunohistochemical localization of basic fibroblast growth factor, platelet derived growth factor, transforming growth factor-beta and tumor necrosis factor-alpha in the pterygium. Acta Histochem 98:195-201.
27. Kwok SK, Ho PC, Leung SF, Sonal KF. 1994. Surgical result of radiation-induced cataract in Chinese patients with nasopharyngeal carcinoma. Dev Ophthalmol 26:14-18.
28. Lai M-S, Hsueh Y-M, Chen C-J, Shyu M-P, Chen S-Y, Kuo T-L, et al. 1994. Ingested inorganic arsenic and prevalence of diabetes mellitus. Am J Epidermiol 139:484-492.
29. Lau AT, Li M, Xie R, He QY, Chiu JF. 2004. Opposed arsenite-induced signaling pathways promote cell proliferation or apoptosis in cultured lung cells. Carcinogenesis 25:212-218.
30. Li DQ, Lee SB, Gunja-Smith Z, Liu Y, Solomon A, Mellor D, et al. 2001. Over-expression of collagenase (MMP-1) and stromelysin (MMP-3) by pterygium head fibroblasts. Arch Ophthalmol 119:71-80.
31. Lin S-F, Tsai R-K, Tung I-C, Sheu M-M. 2006. An epidemiologic study of pterygium in middle-aged and elderly aboriginal populations of the Tao Tribe of Orchid Island in Taiwan. Tzu Chi Med J 18:283-286.
32. Lo M-C, Hsen Y-C, Lin B-K. 1977, Second Report on the Investigation of Arsenic Content in Underground Water in Taiwan. Taichung, Taiwan:Taiwan Provincial Institute of Environmental Sanitation.
33. Luster MI, Simeonova PP. 2004. Arsenic and urinary bladder cell proliferation. Toxicol Appl Pharmacol 198:419-423.
34. Luthra R, Nemesure BB, Wu SY, Xie SH, Leske MC. 2001. Frequency and risk factors for pterygium in the Barbados Eye Study. Arch Ophthalmol 119:1827-1832.
35. Mackenzie FD, Hirst LW, Battistutta D, Green A. 1992. Risk analysis in the development of pterygia. Ophthalmology 99:1056-1061.
36. McCarty CA, Fu CL, Taylor HR. 2000. Epidemiology of pterygium in Victoria, Australia. Br J Ophthalmol 84:289-292.
37. Moran DJ, Hollows FC. 1984. Pterygium and ultraviolet radiation: a positive correlation. Br J Ophthalmol 68:343-346.
38. Nakaishi H, Yamamoto M, Ishida M, Someya I, Yamada Y. 1997. Pingueculae and pterygia in motorcycle policemen. Ind Health 35:325-329.
39. Paula JS, Thorn F, Cruz AA. 2006. Prevalence of pterygium and cataract in indigenous populations of the Brazilian Amazon rain forest. Eye 20:533-536.
40. Payrani SB, Scott WP, Wells JW Jr, Johnson DW, Chobe RJ, Kuruvilla A, et al. 1994. Management of pterygium with surgery and radiation therapy. The North Florida Pterygium Study Group. Int J Radiat Oncol Biol Phys 28:101-103.
41. Rojas JR, Malaga H. 1985. Pterygium in Lima, Peru. Ann Ophthalmol 18:147-149.
42. Saw SM, Tan D. 1999. Pterygium: prevalence, demography and risk factors. Ophthalmic Epidermiol 6:219-228.
43. Shimmura S, Ishioka M, Hanada K, Shimazaki J, Tsubota K. 2000. Telomerase activity and p53 expression in pterygia. Invest Ophthalmol Vis Sci 41:1364-1369.
44. Smith AH, Goycolea M, Haque R, Biggs ML. 1998. Marked increase in bladder and lung cancer mortality in a region of northern Chile due to arsenic in drinking water. Am J Epidemiol 147:660-669.
45. Solomon A, Pires RT, Tsang SC. 2001. Amniotic membrane transplantation after extensive removal of primary and recurrent pterygia. Ophthalmology 108:449-460.
46. Soucy NV, Ihnat MA, Kamat CO, Hess L, Post MJ, Klei LR, et al. 2003. Arsenic stimulates angiogenesis and tumorigenesis in vivo. Toxicol Sci 76:271-279.
47. Tan CS, Lim TH, Koh WP, Liew GC, Hoh ST, Tan CC, et al. 2006. Epidemiology of pterygium on a tropical island in the Riau Archipelago. Eye 20:908-912.
48. Tan DT, Chee SP, Dear KB, Lim AS. 1997a. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol 115:1235-1240.
49. Tan DT, Lim AS, Goh HS, Smith DR. 1997b. Abnormal expression of the p53 tumor suppressor gene in the conjunctiva of patients with pterygium. Am J Ophthalmol 123:404-405.
50. Taylor HR, West SK, Rosenthal FS, Munoz B, Newland HS, Emmett EA. 1989. Corneal changes associated with chronic UV irradiation. Arch Ophthalmol 107:1481-1484.
51. Tseng C-H, Chong C-K, Chen C-J, Tai T-Y. 1996. Dose-response relationship between peripheral vascular disease and ingested inorganic arsenic among residents in blackfoot disease endemic villages in Taiwan. Atherosclerosis 120:125-133.
52. Tseng C-H, Tai T-Y, Chong C-K, Tseng C-P, Lai M-S, Lin B-J, et al. 2000. Long-term arsenic exposure and incidence of non-insulin-dependent diabetes mellitus: a cohort study in arseniasis-hyperendemic villages in Taiwan. Environ Health Perspect 108:847-851.
53. Tseng W-P. 1977. Effects and dose-response relationships of skin cancer and blackfoot disease with arsenic. Environ Health Perspect 19:109-119.
54. Tseng W-P. 1989. Blackfoot disease in Taiwan: a 30-year follow-up study. Angiology 40:547-558.
55. Tsuda T, Babazono A, Yamamoto E, Kurumatani N, Mino Y, Ogawa T, et al. 1995. Ingested arsenic and internal cancer: a historical cohort study followed for 33 years. Am J Epidemiol 141:198-209.
56. U.S. Environmental Protection Agency. 2001. National primary drinking water regulations. Arsenic and clarifications to compliance and new source contaminants monitoring. Final rule. Fed Reg 66:6076-7066.
57. Varinli S, Varinli I, Köksal Erkisi M, Doran F. 1994. Human papillomavirus in pterygium. Cent Afr J Med 40:24-26.
58. Wang C-H, Jeng J-S, Yip P-K, Chen C-L, Hsu L-I, Hsueh Y-M, et al. 2002. Biological gradient between long-term arsenic exposure and carotid atherosclerosis. Circulation 105:1804-1809.
59. Wang H-Z, Chuang S-S, Chen C-W. 1977. The prevalence of pterygia in Pescadores Island. Acta Societatis Ophthalmologicae Sinicae 16:69-75.
60. Wang S-L, Chiou J-M, Chen C-J, Tseng C-H, Chou W-L, Wang C-C, et al. 2003. Prevalence of non-insulin-dependent diabetes mellitus and related vascular diseases in southwestern arseniasis-endemic and nonendemic areas in Taiwan. Environ Health Perspect 111:155-159.
61. Weinstein O, Rosenthal G, Zirkin H, Monos T, Lifshitz T, Argov S. 2002. Overexpression of p53 tumor suppressor gene in pterygia. Eye 16:619-621.
62. Wong TY, Foster PJ, Johnson GJ, Seah SK, Tan DT. 2001. The prevalence and risk factors for pterygium in an adult Chinese population in Singapore: the Tanjong Pagar survey. Am J Ophthalmol 131:176-183.
63. Wu H-Y, Chen K-P, Tseng W-P, Hsu C-L. 1961. Epidemiologic studies on blackfoot disease. I. Prevalence and incidence of the disease by age, sex, year, occupation and geographical distribution. Mem College Med Natl Taiwan Univ 7:33-50.
64. Wu M-M, Kuo T-L, Hwang Y-H, Chen C-J. 1989. Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular diseases. Am J Epidemiol 130:1123-1132.